These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 20398393

  • 1. A comparability study of 5 commercial KRAS tests.
    Oliner K, Juan T, Suggs S, Wolf M, Sarosi I, Freeman DJ, Gyuris T, Baron W, Bakker A, Parker A, Patterson SD.
    Diagn Pathol; 2010 Apr 16; 5():23. PubMed ID: 20398393
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Analytical performance of a PCR assay for the detection of KRAS mutations (codons 12/13 and 61) in formalin-fixed paraffin-embedded tissue samples of colorectal carcinoma.
    Lee S, Brophy VH, Cao J, Velez M, Hoeppner C, Soviero S, Lawrence HJ.
    Virchows Arch; 2012 Feb 16; 460(2):141-9. PubMed ID: 22173329
    [Abstract] [Full Text] [Related]

  • 5. KRAS and BRAF mutation analysis in colorectal adenocarcinoma specimens with a low percentage of tumor cells.
    Lewandowska MA, Jóźwicki W, Żurawski B.
    Mol Diagn Ther; 2013 Jun 16; 17(3):193-203. PubMed ID: 23606169
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas].
    Zhang X, Wang Y, Gao N, Wang J.
    Zhonghua Bing Li Xue Za Zhi; 2014 Feb 16; 43(2):77-82. PubMed ID: 24742565
    [Abstract] [Full Text] [Related]

  • 10. The importance of evaluation of DNA amplificability in KRAS mutation testing with dideoxy sequencing using formalin-fixed and paraffin-embedded colorectal cancer tissues.
    Okayama N, Nishioka M, Hazama S, Sakai K, Suehiro Y, Maekawa M, Sakamoto J, Iwamoto S, Kato T, Mishima H, Oka M, Hinoda Y.
    Jpn J Clin Oncol; 2011 Feb 16; 41(2):165-71. PubMed ID: 20926413
    [Abstract] [Full Text] [Related]

  • 11. Study of KRAS new predictive marker in a clinical laboratory.
    Bando I, Cillero L, Sanz-Ortega J, Llovet P, Pescador P, Ferrer M, de la Hoya M, Sastre J, García ED, Caldés T.
    Clin Transl Oncol; 2012 Dec 16; 14(12):937-42. PubMed ID: 22865324
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Metastatic colorectal cancer KRAS genotyping in routine practice: results and pitfalls.
    Lamy A, Blanchard F, Le Pessot F, Sesboüé R, Di Fiore F, Bossut J, Fiant E, Frébourg T, Sabourin JC.
    Mod Pathol; 2011 Aug 16; 24(8):1090-100. PubMed ID: 21516079
    [Abstract] [Full Text] [Related]

  • 15. Mutation analysis of BRAF exon 15 and KRAS codons 12 and 13 in Moroccan patients with colorectal cancer.
    Bennani B, Gilles S, Fina F, Nanni I, Ibrahimi SA, Riffi AA, Nejjari C, Benajeh DA, El Abkari M, Martin PM, Ouafik L.
    Int J Biol Markers; 2010 Aug 16; 25(4):179-84. PubMed ID: 21161938
    [Abstract] [Full Text] [Related]

  • 16. KRAS and BRAF mutation analysis in routine molecular diagnostics: comparison of three testing methods on formalin-fixed, paraffin-embedded tumor-derived DNA.
    Heideman DA, Lurkin I, Doeleman M, Smit EF, Verheul HM, Meijer GA, Snijders PJ, Thunnissen E, Zwarthoff EC.
    J Mol Diagn; 2012 Aug 16; 14(3):247-55. PubMed ID: 22425762
    [Abstract] [Full Text] [Related]

  • 17. Direct sequencing is a reliable assay with good clinical applicability for KRAS mutation testing in colorectal cancer.
    Wang J, Yang H, Shen Y, Wang S, Lin D, Ma L, Han X, Shi Y.
    Cancer Biomark; 2013 Aug 16; 13(2):89-97. PubMed ID: 23838137
    [Abstract] [Full Text] [Related]

  • 18. Sensitive detection of KRAS mutations in archived formalin-fixed paraffin-embedded tissue using mutant-enriched PCR and reverse-hybridization.
    Ausch C, Buxhofer-Ausch V, Oberkanins C, Holzer B, Minai-Pour M, Jahn S, Dandachi N, Zeillinger R, Kriegshäuser G.
    J Mol Diagn; 2009 Nov 16; 11(6):508-13. PubMed ID: 19797612
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Heterogeneity of colorectal cancer (CRC) in reference to KRAS proto-oncogene utilizing WAVE technology.
    Perez K, Walsh R, Brilliant K, Noble L, Yakirevich E, Breese V, Jackson C, Chatterjee D, Pricolo V, Roth L, Shah N, Cataldo T, Safran H, Hixson D, Quesenberry P.
    Exp Mol Pathol; 2013 Aug 16; 95(1):74-82. PubMed ID: 23528430
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.